Home > Drug List > Nintedanib > Indications of Nintedanib

Indications of Nintedanib

Idiopathic Pulmonary Fibrosis

Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adults.

Chronic Fibrosing Interstitial Lung Disease with a Progressive Phenotype

Nintedanib is indicated for the treatment of chronic fibrosing interstitial lung disease (ILDs) with a progressive phenotype in adults.

Systemic Sclerosis-associated Interstitial Lung Disease

Nintedanib is indicated for slowing the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

FDA，2024.10